20 Camidge Camidge DR DR Bang Bang YJ YJ Kwak Kwak EL EL Iafrate Iafrate AJ AJ Varella-Garcia Varella-Garcia M M Fox Fox SB SB et al et al Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study Lancet Oncol Lancet Oncol 2012 2012 13 13 10 10 1011 1011 1019 1019 22954507 22954507. This evidence concerns the gene ALK and non-small cell lung carcinoma.